News ContraFect Corporation

Equities

CFRXQ

US2123264093

Market Closed - OTC Markets Other stock markets 03:37:58 2024-04-16 pm EDT			5-day change	1st Jan Change
0.021 ^USD	-10.06%		-14.98%	-30.00%

Apr. 12	North American Morning Briefing : Big Banks Kick -2-	DJ
Apr. 05	North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Big Banks Kick -2-	Apr. 12	DJ
North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited	Apr. 05	DJ
Bidding Procedure Approved for ContraFect Corporation	Feb. 09	CI
Motion for Asset Sale Filed by ContraFect Corporation	Jan. 11	CI
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Financial Officer	Dec. 05	CI
ContraFect Corporation Announces Management Resignations	Dec. 05	CI
ContraFect Corporation Announces Resignation of Michael Messinger as Chief Executive Officer	Dec. 05	CI
ContraFect Corporation Filed for Bankruptcy	Dec. 04	CI
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	Nov. 20	DJ
ContraFect Corporation Announces Chief Executive Officer Changes	Nov. 15	CI
ContraFect Corporation Announces Executive Changes	Nov. 15	CI
ContraFect Corporation Appoints Michael Messinger as Chief Financial Officer	Nov. 15	CI
ContraFect Corporation Implements Restructuring Plan Resulting in Reduction to Workforce from A Total of 23 Employees to Five Employee	Nov. 15	CI
ContraFect: Q3 Earnings Snapshot	Nov. 14	AQ
ContraFect Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	Nov. 13	DJ
ContraFect Corporation(OTCPK:CFRX) dropped from S&P TMI Index	Nov. 13	CI
ContraFect Corporation(OTCPK:CFRX) dropped from NASDAQ Composite Index	Nov. 08	CI
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study	23-10-16	AQ
ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development	23-09-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ContraFect Corporation

Equities

CFRXQ

US2123264093

Summary

Filters